Theme: To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology

Hepatology 2016

Renowned Speakers

Hepatology 2016

Track 1: Hepatology

Hepatology is the branch of medicine that incorporates the study of liver, gallbladder, biliary tree, and pancreas function as well as management of their disorders. The study of these organ deals with the understanding of clinical syndrome of non-cirrhotic portal hypertension and Congenital Hepatic Fibrosis; study the biological processes underlying the development of hepatic regeneration and study aspects of viral hepatitis that allow insight into disease mechanisms.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA

Track 2: Diagnosing Liver Diseases

Diagnosis for Liver diseases has been advocated with the intention of intervening to halt its progression. Abnormal liver tests are those that measure synthesis of proteins made by the liver (albumin, clotting factors) or the liver's capacity to metabolize drugs. The impact of diagnosis of hepatitis C virus on quality of life is worse in patients aware of their viral status compared with individuals unaware of their viral status. Ultrasound-based transient elastography is the advanced technology more commonly used for the assessment of chronic liver diseases. It is also used to predict complications in patients with Liver cirrhosis.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 3: HBV and HCV Vaccines

The Food and Drug Administration approved the first vaccine for hepatitis B in 1981. The currently used hepatitis B vaccines are made synthetically. The global market for hepatitis B vaccine is growing at a significant rate due to increasing number of cases with hepatitis B infection. In addition, growing population and growing awareness for improved healthcare facilities is increasing the global market for hepatitis B vaccine. North America dominates the global hepatitis B vaccines market due to increasing prevalence of hepatitis B infection cases and improved healthcare facilities in the region. In addition, government initiatives and more awareness among the people are some of the major factors driving the hepatitis B vaccines market. Asia, followed by Europe, is expected to experience high growth rate in the next few years in hepatitis B vaccines market. China and India are expected to be the fastest growing hepatitis B vaccines markets in Asian region.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France

Track 4: Liver Diseases

Liver is responsible for many critical functions within the body. It helps your body digest food, store energy, and remove poisons. If it becomes diseased or injured, the loss of those functions can cause significant damage to the body. There are over 100 different forms of liver disease that affect men, women and children. These diseases include cirrhosis, alcohol abuse, hepatitis A, B, C, D, and E, Epstein Barr virus (infectious mononucleosis), non-alcoholic fatty liver disease and iron overload (hemochromatosis). The main symptoms of liver imbalance include weakness and fatigue, weight loss, nausea, vomiting, and yellow discoloration of the skin (jaundice).

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA

Track 5: Viral and Non-viral Hepatitis

Treatment of Hepatitis is on the cutting edge of medicine. Hepatitis B virus infection (HBV) has been recognized as a major health problem worldwide and Hepatitis C virus infection is the most common chronic blood borne infection in the United States. Viral hepatitis treatment depends on how active the virus is in your body. Viral hepatitis is the most common cause of hepatitis worldwide. Other causes of non-viral hepatitis include alcoholic hepatitis and autoimmune hepatitis.  

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; Latin and Ibero American Congress of Paediatric Gastroenterology, Hepatology and Nutrition, November 18-21, 2015, Lima, Peru; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 6: Hepatitis Antigens and Antibodies

Hepatitis Be antigen (HBeAg) is found in the early phase of hepatitis B infection soon after hepatitis Bs antigen becomes detectable. Serum levels of both antigens rise rapidly during the period of viral replication. The presence of HBeAg correlates with hepatitis B virus (HBV) infectivity, the number of viral Dane particles, the presence of core antigen in the nucleus of the hepatocyte, and presence of viral DNA polymerase in serum. During recovery from acute hepatitis B, after HBeAg level declines and becomes undetectable, HBe antibody (anti-HBe) appears in the serum. Anti-HBe usually remains detectable for several years after recovery from acute infection.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 7: Hepatocellular Carcinoma and Pancreatic Cancer           

Hepatocellular carcinoma accounts for most liver cancers. This type of liver cancer occurs more often in men than women and is usually seen in people age 50 or older. It is commonly associated with cirrhosis and hepatitis. The incidence of hepatocellular carcinoma is highest in Asia and Africa, where the endemic high prevalence of hepatitis B and hepatitis C strongly predisposes to the development of chronic liver disease and subsequent development of hepatocellular carcinoma. Other risk factors can include a history of alcohol abuse.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; 2016 Gastrointestinal Cancers Symposium, January 21-23, 2016, San Francisco, USA; 31st Annual New Treatments in Chronic Liver Disease, March 19-20, 2016, La Jolla, USA.

Track 8: Pancreatic and Biliary Duct Diseases

The pancreas and biliary tract is crucial secondary organ for the human digestive system as when they don't work properly, it affects the entire body. Pancreatic and biliary tract problems can cause severe abnormalities such as stomach pain, bloating, nausea and vomiting. Anyone with such symptoms, especially when they are severe and long lasting, should see a doctor immediately as to receive perfect care and prevention.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 9: Transplantation and Surgery

Liver transplantation surgery technique to replace a diseased or injured liver with a healthy liver delivered from a healthy person. The liver is involved in various metabolic functioning including metabolism of drugs and toxins, removing degradation products of normal body metabolism (for example clearance of ammonia and bilirubin from the blood), and synthesis of many important proteins and enzymes (such as factors necessary for blood to clot). Doctors or surgeons suggest liver transplant surgery to the patients who suffer from severe Drug-induced liver injury (DILI) or Chronic liver failure. This surgery carries a risk of other complications including infection, liver inflammation, blood clots, liver rejection, memory and thinking problems.

Relevant Conferences:

3rd World Congress on Hepatitis and Liver Diseases Conference, October 17-19, 2016, UAE; 5th World Congress on Virology Conference, December 07-09, 2015, USA; 2nd International Conference on Hepatology Conference, May 09-11, 2016, USA; 5th International Conference and Exhibition on Pathology Conference, May 09-11, 2016, USA; World Pathology Congress, June 16-18, 2016, Spain; National Liver Conference, September 18, 2015, Fort Worth, USA; AHPBA 2017 Annual Meeting, March 29-April 2, 2017, Miami, Florida; International Meeting on Living Donor Liver Transplantation, September 28-29, 2015, Barcelona, Spain; Mayo Clinic Gastroenterology and Hepatology, February 25-28, 2016, Arizona, USA; The Liver Transplant Symposium, November 06-08, 2015, Singapore.

Track 10: Bile formation and Related Diseases

Bile is a fluid that is made and released by the liver and stored in the gallbladder. Bile helps with digestion. It breaks down fats into fatty acids, which can be taken into the body by the digestive tract. Bile contains mostly cholesterol, bile acids and bilirubin. It also contains water, body salts, copper and other metals.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France; Joint Congress of the International Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA

Track 11: Entrepreneurs Investment Meet

Entrepreneurs Investment Meet is a global platform aimed to connect Entrepreneurs, Proposers and the Investors worldwide. It intended to create and facilitate the most optimized and viable business meeting place for engaging people in to constructive discussions, evaluation and execution of promising business ideas. An investor could be able to find out the highest potential investment opportunities, which provide good return on investment. For entrepreneurs, this would be an ideal place to find out suitable investors and partners to start or expand their business.

Relevant Conferences:

International Pancreatic Disorders Conference, May 12-14, 2016, USA; International Pancreatic and Colorectal Cancer Conference, March 29-30, 2016, USA; 2nd International Hepatology Conference, May 09-11, 2016, USA; 6th Gastroenterology and Gastroenterologists Annual Meeting, June 16-18, 2016, USA; European Gastroenterology Conference, October 24-26, 2016, Valencia, Spain; Pancreas and Islet Transplant Association, International Xenotransplantation Association and Cell Transplant Society, November 15-19, 2015, Melbourne, Australia; National Liver Conference, September 18, 2015, Fort Worth, USA; GI and Liver Association of the Americas, September 25-26, 2015, Chicago, USA; French Pancreatic Club 30th Annual Meeting, September 17-18, 2015 Toulouse, France

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

- See more at: http://pancreas.conferenceseries.com/#sthash.sNWH0chy.dpuf

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

- See more at: http://pancreas.conferenceseries.com/#sthash.sNWH0chy.dpuf

On behalf of Hepatology 2016 Organizing Committee, we are pleased to invite Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe to attend 2nd International Conference on Hepatology which is to be held on May 09-11, 2016 at Chicago, USA. The conference highlights the theme “To discuss and share the latest updates and cutting-edge technologies in the field of Hepatology”.

The conference proceedings include symposiums and workshops, keynote speeches, plenary talks, poster sessions and panel discussion on latest research developments in the field of Hepatology.

OMICS International organizes 300+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members. - See more at: http://pancreas.conferenceseries.com/#sthash.Z11s31NP.dpuf

Conference Series LLC organizes 600+ International Conferences Every Year across USA, Europe & Asia with support from 1000 more scientific Societies and publishes 400+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.

Conference Highlights

Hepatology

Diagnosing Liver Diseases

HBV and HCV Vaccines

Liver Diseases

Viral and Non-viral Hepatitis

Hepatitis Antigens and Antibodies

Hepatocellular Carcinoma and Pancreatic Cancer

Pancreatic and Biliary Duct Diseases

Transplantation and Surgery

Bile formation and Related Diseases

Entrepreneurs Investment Meet

Conference Opportunities

For Researchers and Faculty Members:

Speaker Presentations
Poster Display
Symposium hosting (4-5 member team)
Workshop organizing

For Universities, Associations & Societies:

Association Partnering
Collaboration proposals
Academic Partnering
Group Participation

For Students and Research Scholars:

Poster Competition (Winner will get Best Poster Award)
Young Researcher Forum (YRF Award to the best presenter)
Student Attendee
Group registrations

For Business Delegates:

Speaker Presentations
Symposium hosting
Book Launch event
Networking opportunities
Audience participation

For Product Manufacturers:

Exhibitor and Vendor booths
Sponsorships opportunities
Product launch
Workshop organizing
Scientific Partnering
Marketing and Networking with clients

 
Genetic and Metabolic Liver diseases

Hepatology is a branch of medicine concerned with the study, prevention, diagnosis and management of diseases that affect the liver, gallbladder, biliary tree and pancreas. Hepatitis is a medical condition defined by the inflammation of the liver. Most liver damage is caused by 3 hepatitis viruses, called hepatitis A, B and C. However, hepatitis can also be caused by alcohol and some other toxins and infections, as well as from our own autoimmune process (the body attacks itself). About 250 million people globally are thought to be affected by hepatitis C, while 300 million people are thought to be carriers of hepatitis B. According to WHO nearly 500 million people have chronic viral hepatitis worldwide. More than 1 million people die each year from causes related to viral hepatitis, commonly cirrhosis and liver cancer. Approximately 1 in 12 persons worldwide are living with chronic viral hepatitis. Currently, an estimated 5.5 million Americans (approximately 2 to 3 percent of adults) suffer from chronic liver disease or cirrhosis. The combined diagnoses of chronic liver disease, cirrhosis, viral hepatitis, and liver cancer make liver disease one of the 10 leading causes of death in the United States. While death rates from some forms of liver disease are decreasing, those for viral hepatitis and liver cancer are on the rise, both in the U.S. and worldwide. An estimated one quarter of Americans will suffer from a liver or biliary (gallbladder-related) disease at some point during their lifetime. Hepatitis, especially hepatitis C, is a chief cause of liver diseases.

Scope:

This conference will encourage innovative ideas and advanced diagnostic approaches towards the liver disease. It will share recent advancements and knowledge share about liver and pancreatic diseases and treatment strategies. The participant companies can display their product to gain the networks and to promote their upcoming new strategies for the future era.

The main aim of this conference is to gather Hepatologists, Gastroenterologists, Pathologists, Directors/CEO & Industry experts, Professors, Researchers, Scientists and Students of Hepatology and Liver diseases in all areas of  Liver diseases & Therapeutics and to provide an international forum for the dissemination of original research results, new ideas and practical development experiences related to the research.

Associations in USA

  • International Association for the Study of the Liver (IASL)
  • American Association for the Study of Liver Diseases (AASLD)
  • American Hepato-Pancreato-Biliary Association (AHPBA)
  • American Liver Foundation (ALF)
  • Hepatitis Foundation International (HFI)
  • Texas Society for Gastroenterology and Endoscopy (TSGE)

Top Universities in Chicago:

  • Pritzker School of Medicine
  • Feinberg School of Medicine
  • University of Illinois College of Medicine
  • Rush Medical College
  • Loyola University Chicago
  • Midwestern University
  • Rosalind Franklin University of Medicine and Science
  • Southern Illinois University

Pharmaceutical Companies in Chicago:

  • Therpeutic Proteins Inc
  • Eli Lilly-Chicago
  • Horizon Pharmacy USA Inc
  • Campbell Alliance Group Inc
  • Medac Pharma Inc
  • Genetech Industries Inc
  • Legulo Co
  • Global Pharma Device Solutions
  • Milex Products Inc
  • Horsehead Corp
  • Pharmatech USA
  • Iterative Therapeutics Inc
  • Avocet Polymer Technologies
  • Bocce Drugs Wholesaling Lslng
  • Luster Products Inc
  • Tolerogenics Inc
  • Elite Co
  • Best Value Pharmaceuticals
  • Ap Tex Enterprise Inc
  • Alva-Amco Pharmacal Inc
  • Durata Therapeutics Inc
  • Q Pharma Inc

Top 10 Pharmaceutical companies in USA:

  • Pfizer
  • Novartis
  • Sanofi
  • Roche
  • Merck & Co.,
  • GlaxoSmithKline
  • AstraZeneca
  • Eli Lilly & Co.,
  • Abbott Laboratories
  • McKesson
Hepatitis 2015

Conference Series LLC takes a great pride in announcing the commencement of "World Congress on Hepatitis” during July 20-22, 2015 at Hyatt Regency Orlando International Airport, Florida, USA. The conference highlights the theme “Raising global awareness on hepatitis and fighting the stigma surrounding the disease”. It is the annual meeting for the study of Hepatitis.

With the support and contribution of the organizing committee members, we successfully hosted an event at the conference venue. Active participation and generous response were received from the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals, Professors, Researchers, Experts and Students from diverse groups who made this conference as one of the most successful and productive event in 2015 from Conference Series LLC. The conference was marked with the attendance of young researchers, business delegates and students who have driven this event into the path of success.  

The conference was initiated with a warm welcome note from Honorable guests and the Keynote forum lead by Dr. Mark A Feitelson, Associate Director, Temple University, USA. The proceedings went through interactive sessions and panel discussions headed by Dr. Trent W Nichols, AMRI, USA, an honorable Moderator for the conference, who contributed a major part for the success of this event. The event offers a best platform with its well organized scientific program to the audience on the topics Hepatitis Care and Cure, Diagnosis & Liver Pathology/ Case Studies, Assessment of Liver Diseases, Liver  cancer and Hepatocellular carcinoma, Advanced Management of Liver diseases, Clinical Liver Transplantation and Liver Surgery, Advancement in new drug discovery for treatment of hepatitis, Advance Technologies for the treatment of hepatitis and Liver diseases, Current research in Hepatology.

The conference witnessed an amalgamation of peerless speakers, who enlightened the crowd with their enviable research knowledge and on various alluring topics related to the field of hepatitis, carried out through various scientific-sessions and plenary lectures:

  • Does the hepatitis B antigen HBx promote the appearance of liver cancer stem cells? -Dr. Mark A Feitelson, Temple University, USA
  • The Growing Epidemic in HCC from Hepatitis/NASH Cirrhosis in American Veterans-Dr. Trent W Nichols, AMRI, USA
  • Lower GI Bleeding in Patients with cirrhosis- Dr. Maxwell M Chait, Columbia University, USA
  • Impacts of platelets on the prognosis of patients with hepatocellular carcinoma– Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan

Also, the conference proceeding was encouraged through the wonderful symposiums by Dr. Andre Jean Remy, Perpignan Hospital, France, on the title ” New tools of screening viral hepatitis in real life: The French model of care and by Dr. Ehab Abd-El-Atty, Menoufia University, Egypt, on the title “HCC risk factors synergism in Egypt and how to prevent?”

A workshop session was done on “The Cirrhosis Micro-environment and Hepato-carcinogenesis” by Dr. Sen-Yung Hsieh, Chang Gung Memorial Hospital, Taiwan.

OMICS International has taken the privilege of felicitating Hepatitis-2015 Organizing Committee, Editorial Board Members and Keynote Speakers who supported for the success of this event. Conference Series LLC, on behalf of the conference exhibitor congratulate the Best Poster awardee for her outstanding performance in the field of Hepatocellular carcinoma and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. 

We are glad to inform that all accepted abstracts for the conference have been indexed in Conference Series LLC Journal of Liver and Journal of Liver Disease and Transplantation as a special issue.

We sincerely thank the Organizing Committee Members, Editorial Board Members of Conference Series LLC Journals, Participants, Attendees, Sponsors, Exhibitors, and Media partners for their gracious presence and generous support, without which the conference would not have been possible. With the unique feedback from the conference, Conference Series LLC would like to announce the commencement of the "2nd International Conference on Hepatology” May 9-11, 2016 in Chicago, USA.

 

Let us meet again @ 2016 Conferences


Past Reports  Gallery  

Gastro-2015

Conference Series LLC hosted International Conference and Exhibition on Gastrointestinal Therapeutics scheduled during August 25-27, 2015 in Valencia, Spain with the theme, “Advanced Therapeutic Options and Treatment Procedures for Gastrointestinal Disorders".

The conference had multiple sessions including Keynote Presentations, Panel Discussions and Poster Sessions. We received active participation from various scientists, researchers, students and leaders from the field of Gastrointestinal Therapeutics who made this event successful.

Various sessions were carried out with enlightening presentations from speakers all around the world focusing on the below mentioned scientific tracks:

·         Inflammatory Bowel Disease Research vs. Treatment/Management
·         Treatment for Functional GI disorders
·         Gastrointestinal Carcinogenesis and Therapeutics
·         Gastrointestinal Bleeding- Treatment and Management
·         Gastrointestinal Therapeutic Endoscopy- Advancements and Challenges
·         Emerging Therapies for Viral Hepatitis and Liver Fibrosis
·         Recent Advancements and Current Research in Gastrointestinal Therapeutics
·         Probiotics as Gastrointestinal Therapeutics
·         Clinical Nutrition in Gastrointestinal Diseases
·         Gastric Bypass Surgery- Types and Treatment
·         Pancreatic Diseases and Treatment
·         Traditional and Herbal Medications
·         Use of NSAID’s and Antibiotic Therapy
·         Gastrointestinal Pharmacotherapy

The conference was initiated with a series of lectures delivered by both Honorable Guests and Members of the Keynote Forum. The list includes:

  • Dr. Debby Laukens, Ghent University, Belgium
  • Dr. Larry I Good, Good Pharmaceutical Development Company, USA
  • Dr. Ahmed Zaki Helaly, Alexandria University, Egypt
  • Dr. Fratila Ovidiu, University of Oradea, Romania

Conference Series LLC thank all the expert presenters and exuberant participants from all around the World which includes various outside experts, University representatives and other eminent researchers who supported the conference by facilitating the discussion forums.

We would like to thank all of our wonderful Speakers, Conference Attendees, Students, Delegates and Guests for making Gastro-2015 a wonderful event!

With the grand success of Gastro-2015, Conference Series LLC takes the immense pleasure to announce the 7th Global Gastroenterologists Meeting to be held during August 11-12, 2016 in Birmingham, UK.

Let us meet again @ Gastro-2016


Past Reports  Gallery  

Gastroenterology-2015

With the trail of success of our previous conferences, Conference Series LLC hosted the 4th International Conference on Gastroenterology (Gastroenterology-2015) during July 20-22, 2015 at Hyatt Regency Orlando, Florida. Generous response was received from the Editorial Board Members of Conference Series LLC Journals as well as from eminent scientists, talented researchers and young student community. The three day program witnessed thought provoking keynote and plenary presentations from experts in the field of Advances in Gastrointestinal Diseases, Gastrointestinal Oncology, Gastrointestinal Immunology, Advances in Liver Diseases, Gastrointestinal Surgery and Pediatric Urology highlighting the theme “Current Advancements in Gastroenterology".

Gastroenterology-2015 Organizing Committee would like to thank the Moderator of the conference, Dr. Maxwell M. Chait, Columbia University, USA and Dr. Abigail Basson, University of Western Cape, South Africa who contributed meticulously and exuberantly for the smooth functioning of this event.

Conference Series LLC would like to convey a warm gratitude to all the Honorable Guests and Keynote Speakers of Gastroenterology-2015:

  • Maxwell M. Chait, Columbia University, USA
  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Abigail Basson, University of Western cape, South Africa

All the above mentioned Honorable Guests, Keynote Speakers and other speakers gave their fervent and peerless contributions at Gastroenterology-2015. The conference proceedings were carried out through various Scientific-sessions and plenary lectures.

Conference Series LLC congratulates the Best Poster awardees for their outstanding performance and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors. We would like to thank the Poster Competition Judge Pavel Vodicka, Institute of Experimental Medicine, Czech Republic for his valuable time.          

Conference Series LLC also took the privilege of felicitating Gastroenterology-2015, Chair and Co-Chairs whose paramount support escorted the conference to the pinnacle of success.

  • Mary Es. Beaver, Texas Centre of Voice and Swallowing, USA
  • Na Li, The Ohio State University, USA
  • Abigail Basson, University of Western cape, South Africa
  • Joshua Ko, Hong Kong Baptist University, China
  • Nisreene Mahmoud, Cairo University, Egypt
  • Mrinal Pahwa, Sir Ganga Ram Hospital, India

With the enormous feedback from the participants and supporters of Gastroenterology-2015, Conference Series LLC is glad to announce 7th Gastroenterology and Gastroenterologists Annual Meeting during May 16-18, 2016 in San Antonio, USA. We welcome all the eminent researchers, students and delegate participants to take part in this upcoming conference to witness invaluable scientific discussions and contribute to the future innovations in the field of Gastroenterology research.


Past Reports  Proceedings  Gallery  

Gastroenterology-2014

The 3rd International Conference on Gastroenterology & Urology hosted by the Conference Series LLC was successfully held during July 28-30, 2014 in San Francisco, USA. The conference gathered scientists, researchers and leaders from Gastroenterology & Urology societies, government organizations, students who made this conference as one of the most successful event. 

The conference started on July 28 with an opening ceremony in which honorable guest presentations took place on the theme of this Conference "Accelerating New Research and Technologies in Gastroenterology and Urology". Based on this, speaker's discussions included many recommendations. 

Keynote Speakers:

  • Dr. Maxwell Chait, Columbia University College of Physicians and Surgeons, USA
  • Dr. Christos E Constantinou, Stanford University School of Medicine, USA
  • Dr. Amr Amin, UAE University, UAE

All above mentioned keynote speakers gave their energetic and fruitful contributions at 3rd International Conference on Gastroenterology & Urology.  The session chairs/Co chairs have proved their position and contributed a lot for the smooth functioning of the event.

All accepted abstracts have been indexed in the Conference Series LLC Journal of Gastrointestinal & Digestive system as a special issue. Conference Series LLC felicitated all the Organizing Committee Members who enthusiastically participated in the conference and made this meeting a huge success.

With the huge response from scientific fraternity, industries, renowned personalities and Editorial Board Members of Conference Series LLC across the world, we would like to proudly announce “4th International Conference on Gastroenterology & Urology” during July 20-22, 2015 in Florida, USA. We wish to pioneer a way to another outstanding event in the USA.


Past Reports  Gallery  

sponsor

Want to Differentiate your company from your competitors and broaden your competitive edge?

Use our global platform of 3000+ Global Events

  • 25 Million+ Visitors to our Global website (conferenceseries.com)
  • 20000+ Unique Visitors per conference
  • 60000+ Page views per conference

For customized sponsorship opportunities at our conferences, or to place an ad on our websites, contact at sponsors@conferenceseries.com or call at: +1-650-268-9744

To share your views and research, please click here to register for the Conference.

To Collaborate Scientific Professionals around the World

Conference Date May 09-11, 2016
Sponsors & Exhibitors Click here for Sponsorship Opportunities
Speaker Opportunity Day 1 Day 2 Day 3
Poster Opportunity Available

Media Partners

Conferenceseries Destinations


Mail us at

Drop us an email for Program enquiry.
hepatology@conferenceseries.net
Sponsors / Exhibiting / Advertising.
hepatology@conferenceseries.net
General Queries.
hepatology@conferenceseries.net

View Proceedings of Previous Conferences

Hepatitis 2015
Infectious Diseases 2015
Virology 2015
Authorization Policy

By registering for the conference you grant permission to Conferenceseries LLC to photograph, film or record and use your name, likeness, image, voice and comments and to publish, reproduce, exhibit, distribute, broadcast, edit and/or digitize the resulting images and materials in publications, advertising materials, or in any other form worldwide without compensation. Taking of photographs and/or videotaping during any session is prohibited. Contact us for any queries.